| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:34089799 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:34089799 |
| GO:0000280 | Nuclear division | Decreases phenotype | PMID:38308452 |
| GO:0001662 | Behavioral fear response | Increases phenotype | PMID:27814245 |
| GO:0001732 | Formation of cytoplasmic translation initiation complex | Increases phenotype | PMID:3845956 |
| GO:0001822 | Kidney development | Increases phenotype | PMID:30629257 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:28027877; PMID:35678294 |
| GO:0002376 | Immune system process | Affects phenotype | PMID:31918252 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:38308452 |
| GO:0002830 | Positive regulation of type 2 immune response | Affects phenotype | PMID:9931279 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Decreases phenotype | PMID:38308452 |
| GO:0004198 | Calcium-dependent cysteine-type endopeptidase activity | Increases phenotype | PMID:32061141 |
| GO:0004357 | Glutamate-cysteine ligase activity | Decreases phenotype | PMID:32061141 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:32061141; PMID:38308452 |
| GO:0004457 | Lactate dehydrogenase activity | Decreases phenotype | PMID:38308452 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:22269903; PMID:27298056; PMID:28027877; PMID:32061141; PMID:27298056; PMID:32061141; PMID:28027877; PMID:38308452 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:22269903; PMID:27298056; PMID:38308452 |
| GO:0004791 | Thioredoxin-disulfide reductase activity | Decreases phenotype | PMID:28027877 |
| GO:0005388 | P-type calcium transporter activity | Decreases phenotype | PMID:27298056 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:27298056 |
| GO:0005757 | Mitochondrial permeability transition pore complex | Increases phenotype | PMID:35678294 |
| GO:0005975 | Carbohydrate metabolic process | Affects phenotype | PMID:31918252 |
| GO:0006096 | Glycolytic process | Affects phenotype | PMID:33831500 |
| GO:0006163 | Purine nucleotide metabolic process | Affects phenotype | PMID:31918252 |
| GO:0006220 | Pyrimidine nucleotide metabolic process | Affects phenotype | PMID:31918252 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:9694217 |
| GO:0006325 | Chromatin organization | Decreases phenotype | PMID:38308452 |
| GO:0006534 | Cysteine metabolic process | Affects phenotype | PMID:32061141 |
| GO:0006536 | Glutamate metabolic process | Affects phenotype | PMID:31918252; PMID:32061141 |
| GO:0006541 | Glutamine metabolic process | Affects phenotype | PMID:32061141 |
| GO:0006554 | Lysine catabolic process | Affects phenotype | PMID:31918252 |
| GO:0006568 | Tryptophan metabolic process | Affects phenotype | PMID:31918252 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:31918252 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:39921560 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:27456245; PMID:31330227; PMID:32061141; PMID:34062221; PMID:38308452 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:18627028; PMID:22269903; PMID:22966415; PMID:22966415; PMID:28027877; PMID:27180086; PMID:28027877 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:24024199 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:27298056; PMID:32061141; PMID:32991939; PMID:35678294 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:27298056; PMID:28027877; PMID:28027877; PMID:32061141; PMID:32061141; PMID:32179164; PMID:34062221; PMID:34328791; PMID:35678294; PMID:9694217 |
| GO:0006955 | Immune response | Affects phenotype | PMID:3262595 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:34062221 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:22966415; PMID:9694217 |
| GO:0006997 | Nucleus organization | Decreases phenotype | PMID:18627028 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:27298056 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:38308452 |
| GO:0007214 | Gamma-aminobutyric acid signaling pathway | Increases phenotype | PMID:27720918 |
| GO:0007409 | Axonogenesis | Decreases phenotype | PMID:20869980 |
| GO:0007605 | Sensory perception of sound | Decreases phenotype | PMID:34062221 |
| GO:0007612 | Learning | Affects phenotype | PMID:23903816 |
| GO:0007613 | Memory | Affects phenotype | PMID:23903816 |
| GO:0007625 | Grooming behavior | Affects phenotype | PMID:34062221 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:39921560 |
| GO:0008219 | Cell death | Increases phenotype | PMID:26865462; PMID:28526320; PMID:28736149; PMID:30075218; PMID:30769081; PMID:32991939 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:26159257; PMID:28736149 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:23872426; PMID:29581082; PMID:31330227; PMID:31330229; PMID:32949729; PMID:35527009; PMID:37210002 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:31918252 |
| GO:0009636 | Response to toxic substance | Affects phenotype | PMID:23179753; PMID:23872426 |
| GO:0009749 | Response to glucose | Decreases phenotype | PMID:30629257 |
| GO:0009966 | Regulation of signal transduction | Affects phenotype | PMID:23903816 |
| GO:0010470 | Regulation of gastrulation | Affects phenotype | PMID:28184906 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:37967789 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:23203475; PMID:23872426; PMID:24816296; PMID:25841707; PMID:27667695; PMID:27720909; PMID:28001369; PMID:29581082 |
| GO:0010977 | Negative regulation of neuron projection development | Increases phenotype | PMID:29261810 |
| GO:0014005 | Microglia development | Decreases phenotype | PMID:31270303 |
| GO:0014902 | Myotube differentiation | Decreases phenotype | PMID:29104120 |
| GO:0015694 | Mercury ion transport | Increases phenotype | PMID:28536007 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:22269903; PMID:24024199; PMID:27178136; PMID:28027877; PMID:29258870; PMID:30769081; PMID:34062221 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:30503815 |
| GO:0017148 | Negative regulation of translation | Affects phenotype | PMID:3845956 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:29258870; PMID:34062221 |
| GO:0019227 | Neuronal action potential propagation | Increases phenotype | PMID:36565944 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:38308452 |
| GO:0019646 | Aerobic electron transport chain | Decreases phenotype | PMID:25601988 |
| GO:0023041 | Neuronal signal transduction | Affects phenotype | PMID:38065418 |
| GO:0030041 | Actin filament polymerization | Decreases phenotype | PMID:28526320 |
| GO:0030073 | Insulin secretion | Affects phenotype | PMID:23202902 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:33831500 |
| GO:0030264 | Nuclear fragmentation involved in apoptotic nuclear change | Affects phenotype | PMID:9144456 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:37210002 |
| GO:0030335 | Positive regulation of cell migration | Affects phenotype | PMID:29581082 |
| GO:0030399 | Autophagosome membrane disassembly | Decreases phenotype | PMID:27667695 |
| GO:0031175 | Neuron projection development | Affects phenotype | PMID:30075218; PMID:33454822; PMID:36565944 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:28821999; PMID:31330229 |
| GO:0032310 | Prostaglandin secretion | Increases phenotype | PMID:28958600 |
| GO:0032469 | Endoplasmic reticulum calcium ion homeostasis | Affects phenotype | PMID:35678294 |
| GO:0032774 | Rna biosynthetic process | Decreases phenotype | PMID:28027877 |
| GO:0032776 | Dna methylation on cytosine | Increases phenotype | PMID:33454822 |
| GO:0033138 | Positive regulation of peptidyl-serine phosphorylation | Decreases phenotype | PMID:28821999 |
| GO:0034440 | Lipid oxidation | Affects phenotype | PMID:38308452 |
| GO:0034976 | Response to endoplasmic reticulum stress | Increases phenotype | PMID:33454823 |
| GO:0035640 | Exploration behavior | Affects phenotype | PMID:34062221 |
| GO:0035641 | Locomotory exploration behavior | Decreases phenotype | PMID:28821999 |
| GO:0036164 | Cell-abiotic substrate adhesion | Decreases phenotype | PMID:34328791; PMID:37258240 |
| GO:0036269 | Swimming behavior | Affects phenotype | PMID:34062221 |
| GO:0036445 | Neuronal stem cell division | Affects phenotype | PMID:34089799 |
| GO:0042116 | Macrophage activation | Increases phenotype | PMID:38308452 |
| GO:0042133 | Neurotransmitter metabolic process | Affects phenotype | PMID:31918252 |
| GO:0042417 | Dopamine metabolic process | Affects phenotype | PMID:25601988 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:23202902; PMID:27814245; PMID:30629257 |
| GO:0043005 | Neuron projection | Decreases phenotype | PMID:37210002 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:22966415; PMID:23202902; PMID:31330229; PMID:37967789; PMID:9144456 |
| GO:0043408 | Regulation of mapk cascade | Increases phenotype | PMID:28958600 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:20869980; PMID:31330229 |
| GO:0043966 | Histone h3 acetylation | Decreases phenotype | PMID:33454822; PMID:39187442 |
| GO:0043970 | Histone h3-k9 acetylation | Affects phenotype | PMID:36565944 |
| GO:0044154 | Histone h3-k14 acetylation | Decreases phenotype | PMID:33454822; PMID:36565944 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:18627028; PMID:31706035; PMID:31850806; PMID:31878059; PMID:32870474; PMID:32991939; PMID:34328791; PMID:35678294; PMID:36813253; PMID:38323385; PMID:38692911 |
| GO:0045333 | Cellular respiration | Affects phenotype | PMID:33831500 |
| GO:0045665 | Negative regulation of neuron differentiation | Increases phenotype | PMID:29261810 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:31330227 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:32949729 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:34062221 |
| GO:0046415 | Urate metabolic process | Affects phenotype | PMID:31918252 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:38308452 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:8295846 |
| GO:0047823 | D-glutamyltransferase activity | Decreases phenotype | PMID:32061141 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Increases phenotype | PMID:31175882; PMID:39921560 |
| GO:0050893 | Sensory processing | Affects phenotype | PMID:31918252 |
| GO:0051560 | Mitochondrial calcium ion homeostasis | Affects phenotype | PMID:35678294 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:35678294 |
| GO:0060612 | Adipose tissue development | Affects phenotype | PMID:29850906; PMID:30629257 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:34062221; PMID:38308452 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:39921560 |
| GO:0071763 | Nuclear membrane organization | Decreases phenotype | PMID:27298056 |
| GO:0071897 | Dna biosynthetic process | Decreases phenotype | PMID:28027877 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:32061141; PMID:34328791; PMID:36813253 |
| GO:0090559 | Regulation of membrane permeability | Affects phenotype | PMID:28027877 |
| GO:0097202 | Activation of cysteine-type endopeptidase activity | Increases phenotype | PMID:25841707 |
| GO:0098532 | Histone h3-k27 trimethylation | Increases phenotype | PMID:33454822; PMID:36565944; PMID:39187442 |
| GO:0098743 | Cell aggregation | Increases phenotype | PMID:37258240 |
| GO:1900103 | Positive regulation of endoplasmic reticulum unfolded protein response | Increases phenotype | PMID:37967789 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:27667695; PMID:28821999 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:29522201 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Affects phenotype | PMID:21781743 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Affects phenotype | PMID:9144456 |
| GO:1902667 | Regulation of axon guidance | Affects phenotype | PMID:23903816 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:34089799 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:27456245 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27178136; PMID:27298056; PMID:28526320; PMID:28736149; PMID:31850806 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:31330227; PMID:31330229 |
| GO:1904179 | Positive regulation of adipose tissue development | Increases phenotype | PMID:27814245 |
| GO:1904456 | Negative regulation of neuronal action potential | Increases phenotype | PMID:39187442 |
| GO:1904480 | Positive regulation of intestinal absorption | Increases phenotype | PMID:31175882 |
| GO:1905146 | Lysosomal protein catabolic process | Decreases phenotype | PMID:27667695 |
| GO:1905898 | Positive regulation of response to endoplasmic reticulum stress | Increases phenotype | PMID:31330229 |
| GO:2000379 | Positive regulation of reactive oxygen species metabolic process | Increases phenotype | PMID:23202902 |
| GO:2000786 | Positive regulation of autophagosome assembly | Affects phenotype | PMID:27667695 |
| GO:2001272 | Positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | Increases phenotype | PMID:31330229 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.